Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study.
about
Effect of statin treatment on short term mortality after pneumonia episode: cohort studyVaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in DenmarkA framework for understanding cancer comparative effectiveness research data needsEffect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adultsDoubly robust estimation of causal effectsBig data for population-based cancer research: the integrated cancer information and surveillance system.Using claims data to predict dependency in activities of daily living as a proxy for frailty.Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.Nonexperimental comparative effectiveness research using linked healthcare databasesStatin use and mortality in rheumatoid arthritis: a general population-based cohort studyPropensity score methods for confounding control in nonexperimental researchPropensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs.Application of marginal structural models in pharmacoepidemiologic studies: a systematic review.Red blood cell transfusion and mortality in trauma patients: risk-stratified analysis of an observational studyIncreasing medication adherence and income assistance access for first-episode psychosis patients.Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study.Methylergonovine maleate and the risk of myocardial ischemia and infarction.Instrumental variable applications using nursing home prescribing preferences in comparative effectiveness researchStatins and the risk of type 2 diabetes mellitus: cohort study using the UK clinical practice pesearch datalinkApples and oranges? Interpretations of risk adjustment and instrumental variable estimates of intended treatment effects using observational data.A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent.Active safety monitoring of new medical products using electronic healthcare data: selecting alerting rulesCardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database.Investigating differences in treatment effect estimates between propensity score matching and weighting: a demonstration using STAR*D trial data.Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study.An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia.On regression adjustment for the propensity score.Comparison of different approaches to confounding adjustment in a study on the association of antipsychotic medication with mortality in older nursing home patients.Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort studyControlling Time-Dependent Confounding by Health Status and Frailty: Restriction Versus Statistical Adjustment.Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care.Head to head comparison of the propensity score and the high-dimensional propensity score matching methods.Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysisTotal joint arthroplasty and the risk of myocardial infarction: a general population, propensity score-matched cohort studyGynecologic cancer outcomes in the elderly poor: A population-based study.Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy.Role of disease risk scores in comparative effectiveness research with emerging therapiesDisease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study.More realistic power estimation for new user, active comparator studies: an empirical example.
P2860
Q28741391-CE4DF0FA-06B6-4101-8FD2-A76597248891Q30416264-4DFDBEF7-B378-41B0-98EA-3060CCAFCCF8Q30416607-30163A7B-04D7-4ACB-BFA7-F9B085C5A878Q30418160-A4A6F08E-14EE-4661-B8A5-1799B8B1808BQ30418988-6E5B2EDA-22FF-423E-87D0-F0AFCC63219DQ30499313-8365AFD1-0522-49FF-A6D1-2BAD967461E2Q30837676-710348AB-FD67-4485-9296-680D0ED8073CQ30863566-8C02DE23-A3D8-42C6-A525-5287FA521284Q33552609-0AA736BB-A817-4764-9E76-B2AD533EA264Q33576469-0E23CA05-F955-4DE8-A511-1E847F2CDBB7Q33588462-A6C7ECFD-4AED-4225-B658-8EF3F58F0550Q33654170-3CD79B38-1249-4414-9E4B-BF5C0CDA6155Q33680604-209E97E6-E55D-4121-89FC-A4932956DB30Q33707284-B0DC4958-3203-43A7-B5D9-32EDBC9E2566Q33768772-6A4AF041-1846-4C77-90FA-35F90B2439CEQ33773223-47C563A5-A31E-483A-9DD9-DEDA1C5D0D76Q33887897-81635B00-1340-4228-A3DB-17D22EF05815Q33922033-4DEDF2D2-26A7-4E5D-B5BE-F7A45F27B0BAQ33976565-4780953B-9073-4A28-AB89-4DA57A35BA62Q33986300-DB5B5A82-23E5-4D4B-A96C-5692B2871DE5Q34074907-CCD413BA-462E-4946-8D26-6EAC299E6E98Q34133971-DAC5A210-CF3B-4FA0-BA24-E06CB79CEBDDQ34135347-47BB18B9-1821-436A-93EB-EB06EE485BBFQ34144971-4FDB4258-D467-46FC-9DCE-5A62DC6F4EE2Q34529168-7C29AB54-56CD-47A4-87D4-0E3367D558E5Q34681579-C77A0722-57B0-4F12-8C11-92F19C402C8CQ34773987-C07B7E39-1FF4-47FC-B9D9-97ADC923A1BEQ35168264-16382C6A-8F6F-4737-9260-52E702A0679EQ35627432-56174D8F-3AEB-41A8-8C3C-F1CA2C397BC8Q35775454-6C415EAE-B762-4A88-B06C-532F4BE2C23CQ35775682-AC1365C3-1D4B-4B6D-8855-B9A13930AE8DQ35875543-CD69A267-B4CE-40BF-8BC4-05D72A449D89Q35927675-89C86529-28A6-4777-A2AA-55D8FF8111AEQ35961843-ED4BDF00-AF2E-47E0-A882-29170D47F6F5Q36090209-41DA5872-560A-47F3-9651-632D76791E7BQ36117707-CBC40FC2-E39A-4501-8444-F1A201B61C9CQ36248959-BFAB4BEE-93F4-439D-A1C8-249882C63760Q36266471-132E1825-279E-4587-8F68-592D188D2291Q36573102-54097A49-38FC-4CD0-8892-4CE2C004D062Q36678149-96CA6649-7E50-44E9-8F70-BFAD31352567
P2860
Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment effects in the prese ...... tribution--a simulation study.
@ast
Treatment effects in the prese ...... tribution--a simulation study.
@en
Treatment effects in the prese ...... tribution--a simulation study.
@nl
type
label
Treatment effects in the prese ...... tribution--a simulation study.
@ast
Treatment effects in the prese ...... tribution--a simulation study.
@en
Treatment effects in the prese ...... tribution--a simulation study.
@nl
prefLabel
Treatment effects in the prese ...... tribution--a simulation study.
@ast
Treatment effects in the prese ...... tribution--a simulation study.
@en
Treatment effects in the prese ...... tribution--a simulation study.
@nl
P2860
P50
P356
P1476
Treatment effects in the prese ...... stribution--a simulation study
@en
P2093
Jerry Avorn
Robert J Glynn
P2860
P304
P356
10.1093/AJE/KWQ198
P407
P577
2010-08-17T00:00:00Z